BackArterra Bioscience Overview

Arterra Bioscience Profit Margin

Latest profit margin for Arterra Bioscience: 37.17% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

24.51%
↓ 41.90% YoY

As of Jun 2026

Annual Profit Margin (TTM)

37.17%
↑ 6.52% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Arterra Bioscience (ARBS.MI) FAQ

Arterra Bioscience (ARBS.MI) currently reports a profit margin of 37.17% as of June 2026. That compares with 34.89% in the prior-year period — up 6.5% year over year. That is above the Healthcare sector average of 21.75%. Use the charts on this page to explore Arterra Bioscience's profit margin history and peer comparisons.

Arterra Bioscience's profit margin increased from 34.89% to 37.17% — a 6.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Arterra Bioscience's profit margin of 37.17% is higher than the Healthcare sector average of 21.75%. That is roughly 70.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Arterra Bioscience's current 37.17% should be judged against Healthcare norms (sector average: 21.75%) and against ARBS.MI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 37.17%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.75%. From there, open related valuation or income-statement pages for Arterra Bioscience, and consider following ARBS.MI for alerts when major investors trade the stock.

Questions & Answers